EGFR-HER2 inhibitor Nazartinib mesylate, Purity ≥98%

Cat. No.: X24-05-ZQ683

EGFR-HER2 inhibitor Nazartinib mesylate, Purity ≥98%

Synonym: 1508250-72-3; EGF816 (mesylate); EGF 816; EGF-816; EGFR-HER2 inhibitor

  • CAS Number: 1508250-72-3
  • Compound CID: 91809207
Product Size
1 mg; 5 mg; 10 mg
Price
Datasheet
MSDS
Properties
Description
Nazartinib mesylate is a compound that blocks the activity of the epidermal growth factor receptor (EGFR) and human epidermal growth factor receptor 2 (HER2), both of which are involved in driving the growth and proliferation of certain types of cancer cells. It targets EGFR (L858/T790MR).
Molecular Weight
591.12
Molecular Formula
C27H35ClN6O5S
Targets
EGFR (L858/T790MR): 31 nM (Ki)
Form
Lyophilized powder
Purity
≥98%
Identity
Confirmed by NMR/HPLC/MS.
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Nazartinib mesylate can be used to explore its therapeutic potential as a third-generation EGFR inhibitor.
Storage
Store at -20ºC.
Related Products

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.